Premium
Warfarin dose requirement for patients with both VKORC1 3673A/A and CYP2C9*3/*3 genotypes
Author(s) -
Fukuda Tsuyoshi,
Tanabe Tomoko,
Ohno Masako,
Tougou Katsuhiko,
Fujio Yasushi,
Azuma Junichi,
Yamamoto Isamu,
Takeda Akira
Publication year - 2006
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1016/j.clpt.2006.08.005
Subject(s) - medicine , clinical pharmacology , pharmaceutical sciences , pharmacology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom